: Natco Pharma Limited on Monday said the US Food and Drug Administration (FDA) has issued an establishment inspection report for its formulations facility in Kothur Village, Telangana.
The drug-maker said the report was issued for the facility which was inspected between May 30 and June 5 by the FDA authorities.
The company had earlier said the US drug regulator had issued nine observations for the facility.
Disclaimer: No Business Standard Journalist was involved in creation of this content
